• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

科学、伦理与纳米技术治理的“问题”。

Science, ethics, and the "problems" of governing nanotechnologies.

机构信息

University of Wisconsin School of Medicine and Public Health, USA.

出版信息

J Law Med Ethics. 2009 Winter;37(4):749-58. doi: 10.1111/j.1748-720X.2009.00445.x.

DOI:10.1111/j.1748-720X.2009.00445.x
PMID:20122114
Abstract

Commentators continue to weigh in on whether there are ethical, social, and policy issues unique to nanotechnology, whether new regulatory schemes should be devised, and if so, how. Many of these commentaries fail to take into account the historical and political environment for nanotechnologies. That context affects regulatory and oversight systems as much as any new metrics to measure the effects of nanoscale materials, or organizational changes put in place to facilitate data analysis. What comes to count as a technical or social "problem" says much about the sociotechnical and political-historical networks in which technologies exist. This symposium's case studies provide insight into procedural successes and failures in the regulation of novel products, and ethical or social analyses that have attended to implications of novel, disruptive technologies. Yet what may be needed is a more fundamental consideration of forms of governance that may not just handle individual products or product types more effectively, but may also be flexible enough to respond to radically new technological systems. Nanotechnology presents an opportunity to think in transdisciplinary terms about both scientific and social concerns, rethink "knowns" about risk and how best to ameliorate or manage it, and consider how to incorporate ethical, social, and legal analyses in the conceptualization, planning, and execution of innovations.

摘要

评论员继续权衡纳米技术是否存在独特的伦理、社会和政策问题,是否应该设计新的监管方案,如果是,应该如何设计。许多这些评论都没有考虑到纳米技术的历史和政治环境。这种背景不仅影响衡量纳米材料影响的新指标或为促进数据分析而采取的组织变革,也影响监管和监督系统。被视为技术或社会“问题”的东西,在很大程度上反映了技术所存在的社会技术和政治历史网络。本次专题讨论会的案例研究深入了解了新型产品监管中的程序成功和失败,以及关注新型颠覆性技术影响的道德或社会分析。然而,可能需要更深入地考虑治理形式,这些形式不仅可以更有效地处理单个产品或产品类型,而且还可以灵活应对全新的技术系统。纳米技术为以跨学科的方式思考科学和社会问题提供了机会,重新思考风险的“已知”以及如何最好地减轻或管理风险,并考虑如何在创新的概念化、规划和执行中纳入道德、社会和法律分析。

相似文献

1
Science, ethics, and the "problems" of governing nanotechnologies.科学、伦理与纳米技术治理的“问题”。
J Law Med Ethics. 2009 Winter;37(4):749-58. doi: 10.1111/j.1748-720X.2009.00445.x.
2
Governance of nanotechnology and nanomaterials: principles, regulation, and renegotiating the social contract.纳米技术和纳米材料的治理:原则、监管和重新协商社会契约。
J Law Med Ethics. 2009 Winter;37(4):706-23. doi: 10.1111/j.1748-720X.2009.00442.x.
3
What does the history of technology regulation teach us about nano oversight?技术监管的历史能给纳米监管带来什么启示?
J Law Med Ethics. 2009 Winter;37(4):724-31. doi: 10.1111/j.1748-720X.2009.00443.x.
4
Problem formulation and option assessment (PFOA) linking governance and environmental risk assessment for technologies: a methodology for problem analysis of nanotechnologies and genetically engineered organisms.问题陈述和方案评估(PFOA)将技术治理和环境风险评估联系起来:纳米技术和基因工程生物体问题分析的方法。
J Law Med Ethics. 2009 Winter;37(4):732-48. doi: 10.1111/j.1748-720X.2009.00444.x.
5
Evaluating oversight systems for emerging technologies: a case study of genetically engineered organisms.评估新兴技术的监督系统:以基因工程生物体为例。
J Law Med Ethics. 2009 Winter;37(4):546-86. doi: 10.1111/j.1748-720X.2009.00431.x.
6
Demand for command: responding to technological risks and scientific uncertainties.指令需求:应对技术风险与科学不确定性。
Med Law Rev. 2013 Winter;21(1):11-38. doi: 10.1093/medlaw/fws042. Epub 2013 Jan 17.
7
The politicization of science and technology: its implications for nanotechnology.科学技术的政治化:及其对纳米技术的影响。
J Law Med Ethics. 2006 Winter;34(4):658-66. doi: 10.1111/j.1748-720X.2006.00084.x.
8
Developing U.S. oversight strategies for nanobiotechnology: learning from past oversight experiences.制定美国纳米生物技术监督战略:从过去的监督经验中学习。
J Law Med Ethics. 2009 Winter;37(4):688-705. doi: 10.1111/j.1748-720X.2009.00441.x.
9
Introduction: The challenge of developing oversight approaches to nanobiotechnology.引言:开发纳米生物技术监督方法面临的挑战。
J Law Med Ethics. 2009 Winter;37(4):543-5. doi: 10.1111/j.1748-720X.2009.00430.x.
10
Transnational models for regulation of nanotechnology.纳米技术监管的跨国模式。
J Law Med Ethics. 2006 Winter;34(4):714-25. doi: 10.1111/j.1748-720X.2006.00091.x.

引用本文的文献

1
NANOTECHNOLOGY, NANOMEDICINE; ETHICAL ASPECTS.纳米技术、纳米医学;伦理方面。
Rev Rom Bioet. 2015 Jul-Sep;13(3).